Recall Record

Salt Lake City, UT, United States

BioFire Diagnostics, LLC recalls

34 recalls recorded since 2018, most recently on 12 August 2026. 21 are listed as ongoing. Status and classification are as published by the FDA.

Recalls34
Ongoing (FDA)21
Terminated or completed13
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
12 August 2026
Reason
Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
Distribution
Worldwide - U.S. Nationwide distribution including in the states and territory of AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY. The countries of Unite
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0150-2027, Z-0149-2027, Z-0148-2027

Ongoing Class II Medical devices

Recall started
24 June 2026
Reason
Due to increase in false negative results
Distribution
U.S. Nationwide distribution in the states of AL, AR, IA, IL, KS, LA, MN, MO, TX, and WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-2936-2026

Ongoing Class II Medical devices

Recall started
22 April 2026
Reason
Contamination to in-vitro diagnostic test may result in false positives.
Distribution
Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, Morocco, Slovenia, Romania, Dominican Republic, Serbia.
Initiated
Voluntary: Firm initiated
Recall number
Z-2067-2026

Ongoing Class II Medical devices

Recall started
1 April 2026
Reason
Respiratory/sore throat panel test may result in false negative results and control failures.
Distribution
US Nationwide distribution in the states of MS, TX MN, VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2081-2026

Ongoing Class II Medical devices

Recall started
22 October 2025
Reason
Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.
Distribution
US:AZ, FL,GA,ID NC, NH, NJ, NY, OR, PA, SC OUS: None
Initiated
Voluntary: Firm initiated
Recall number
Z-0602-2026

Ongoing Class II Medical devices

Recall started
30 April 2025
Reason
Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.
Distribution
International distribution in the country of Singapore.
Initiated
Voluntary: Firm initiated
Recall number
Z-1877-2025

Ongoing Class II Medical devices

Recall started
27 February 2025
Reason
Increased risk of control failures and false negative test results with multiplexed nucleic acid test.
Distribution
OUS International Distribution to countries of: France, Italia, Spain, Switzerland, Israel
Initiated
Voluntary: Firm initiated
Recall number
Z-1518-2025

Ongoing Class II Medical devices

Recall started
7 August 2024
Reason
Some automated in vitro diagnostic modules and instruments manufactured or serviced between May 2022 and May 2024 were calibrated with internal equipment that may lead modules and instruments to report higher melting temperatures, which may lead to erroneous results including false positive Salmonella, Giardia lamblia, false positive/negative Norovirus, and false negative MRSA.
Distribution
Worldwide - US Nationwide distribution including in the states of NC, TX, OH, CA, KS, AL, WA, NY, PA, IL, WI, KY, LA, NE, FL, UT, IA, SC, VA, AZ, CO, WV, MO, TN, MN, DC, DE, OK, WY, IN, NJ, NM, ID, OR, MS, SD, MI, MT, GA, HI, NV, MD, MA, AR, NH, PR, ND, VT, CT, AK, ME, RI and the countries of Korea,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3122-2024, Z-3123-2024

Ongoing Class II Medical devices

Recall started
19 June 2024
Reason
If blood culture identification panel is used in conjunction with specific lots of culture media bottles, then false positive Serratia marcescens results may occur, due to an increased level of non-viable organism from serratia marcescens targets in culture media bottles, false positive result may lead to an inappropriate change in patient therapy.
Distribution
Worldwide - US Nationwide distribution including in the states of FL, IL, KY, CO, KS, NC, AK, NY, ND, CA, TX, MD, GA, OH, WI, SD, LA, MT, VA, IA, MO, MA, WV, NE, OK, AZ, OR, SC, MI, IN, ID, TN, WA, NM, NJ, AR, AL, MN, NH, NV, PA, WY, MS, CT and the countries of AE, AM, AR, AT, BA, BG, BH, BN, BR, CA
Initiated
Voluntary: Firm initiated
Recall number
Z-2456-2024

Ongoing Class II Medical devices

Recall started
10 June 2024
Reason
Pneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer.
Distribution
Worldwide - US Nationwide distribution in the states of WV, IN, AL and the countries of France, Italia, Spain, Greece, Japan Ltd, Singapore, Chile, Taiwan, Israel, Romania, Ecuador, Serbia.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2683-2024, Z-2682-2024

Ongoing Class II Medical devices

Recall started
16 May 2024
Reason
Due to increase of false positive Vibrio/Vibrio Cholerae results when using a certain transport medium.
Distribution
U.S.: Nationwide - AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, Virgin Island, VT, WA, WI, WV, and WY. O.U.S.: Worldwide - AR, AU, AT, BE, BR, CA,
Initiated
Voluntary: Firm initiated
Recall number
Z-2514-2024

Ongoing Class II Medical devices

Recall started
26 January 2024
Reason
Due to potential signals of increased false positive Norovirus results when using the gastrointestinal (GI) panel.
Distribution
Worldwide - U.S. Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, Guam, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, US Virgin Island, VT, WA, WI, WV, and W
Initiated
Voluntary: Firm initiated
Recall number
Z-1140-2024

Ongoing Class II Medical devices

Recall started
26 January 2024
Reason
Due to a trend in false positive Candida tropicalis results on blood culture panel when using certain BD BACTEC vial mediums
Distribution
Worldwide - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, Guam, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. The
Initiated
Voluntary: Firm initiated
Recall number
Z-1139-2024

Ongoing Class II Medical devices

Recall started
14 December 2023
Reason
Their is a potential for false positive results when using Pneumonia panel.
Distribution
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY and the countries of Argentina, Bolivia, Brazil,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0993-2024, Z-0994-2024

Ongoing Class II Medical devices

Recall started
27 November 2023
Reason
A manufacturing event may contribute to elevated rates of false negative results while using gastrointestinal panel and respiratory panel, which could lead to inappropriate antibiotic treatment, no treatment, delay of treatment, and may provide false assurance to someone with a true infection, delayed identification of an outbreak, and may result in additional transmission.
Distribution
US: NC, MO, NE, CT, IL, TN, NJ, OH, MA, CA, FL, UT, IA, KS, TX, MD
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0704-2024, Z-0703-2024

Ongoing Class II Medical devices

Recall started
17 October 2023
Reason
Routine quality control testing of affected blood culture identification panel with affected control panel may need to be amended, due to control panel/instrument characteristic changes, that lead C. tropicalis to be amplified in some portion of test runs, but then it's reported as "Not Detected" because the assay amplicon Tm is outside the acceptable limit assigned for calling positive results.
Distribution
Worldwide Distribution: US (nationwide): DE, OH, NY, IL, KY, FL, GA, KS, CA, WI, NC,, AK, PA, MN, ND, IN, AR, CO, UT, TX, AL, NJ, MD, SD, LA, OR, MA, ID, NE, MT, VA, IA, MO, WV, TN, MI, WY, SC, AZ, WA, NH, OK, HI, MS, DC, VT, CT, NM, RI, ME, NV; and OUS (foreign) to countries of: Algeria, Angola,
Initiated
Voluntary: Firm initiated
Recall number
Z-0451-2024

Ongoing Class II Medical devices

Recall started
17 October 2023
Reason
Due to an increased risk of degradation of the power entry switch resulting from arcing inside of the power switch that may result in carbon build-up on the switch contacts. The carbon build-up may lead to excess heating inside of the power switch, subsequently leading to deformation of the power switch case. The deformation can create an opportunity for a power switch electrical short. In addition to an electrical short, deformation may result in an open circuit causing the power switch to fail. This event would only occur after the product is in use.
Distribution
Worldwide - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, N, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, Virgin Island, VT, WA, WI, WV, and W
Initiated
Voluntary: Firm initiated
Recall number
Z-0353-2024

Ongoing Class II Medical devices

Recall started
8 May 2023
Reason
Due to manufacturing issue, panels may result in false negative results.
Distribution
US: CA CO CT FL GA IA IL IN LA MA MI MO MT NC NE NJ NM NY OH OK PA TN UT WV OUS: Canada, India, Japan, Singapore, Colombia
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2439-2023, Z-2440-2023

Ongoing Class II Medical devices

Recall started
25 April 2023
Reason
The firm has identified an increased risk of obtaining false positive Cryptosporidium results from customers using the BIOFIRE¿ FILMARRAY¿ Gastrointestinal (GI) Panel
Distribution
US:DE, AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WV, WY. OUS: AD, AE, AI, AR, AT, AU, BD, BE, BF, BG, BH, BR, CA, CH, CL, CN, CO, CY, CZ, DE,
Initiated
Voluntary: Firm initiated
Recall number
Z-2588-2023

Ongoing Class II Medical devices

Recall started
8 March 2023
Reason
Due to manufacturing issue, Gastrointestinal (GI) Panel may result in false negative results.
Distribution
US Nationwide distribution in the states of AR, CA, DC, IL, KS, LA, MN, NC, NY, OK, WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1392-2023

Ongoing Class II Medical devices

Recall started
1 February 2023
Reason
Due to temperature excursions with products (products being stored outside of the required temperature specifications) that may cause a reduction in performance. The temperature excursion was as a result of shipping delays.
Distribution
U.S. Nationwide distribution in the states of FL and GA.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1251-2023, Z-1252-2023, Z-1253-2023

Terminated Class II Medical devices

Recall started
11 October 2021
Terminated
10 August 2023
Reason
Due to an increased risk of false positive Acinetobacter calcoaceticus- baumannii complex results. The cause may be as a due to non-viable contamination in the blood culture vials.
Distribution
Worldwide distribution - U.S. Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and WY. The Countries of Algeria, Argentin
Initiated
Voluntary: Firm initiated
Recall number
Z-0312-2022

Terminated Class II Medical devices

Recall started
20 July 2021
Terminated
16 December 2022
Reason
Due to product complaints received for false negative results (dropouts) with blood culture identification panel potential caused by a pouch manufacturing error.
Distribution
U.S. Nationwide Distribution in the states of : FL, MI, NJ, OH, VA and WI. O.U.S.: None
Initiated
Voluntary: Firm initiated
Recall number
Z-2245-2021

Terminated Class II Medical devices

Recall started
7 June 2021
Terminated
31 July 2023
Reason
Due to real-time stability study failures resulting in increase rate of false negative results between the 6 to 12 month expiry time-frame.
Distribution
U.S.: AK, AL, AZ, CA, CA, CO, CT, DC, DE, FL, GA, Guam, HI, IA, ID, IL, IN, IN, KS, KY, KY, LA, MA, MD, ME, MI, MI, MN, MO, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, SC, TN, TX, UT, VA, VT, WA, WI, WV and WY. O.U.S.: Algeria, Angola, Anguilla, Argentina, Australia, Aust
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2039-2021, Z-2040-2021

Terminated Class II Medical devices

Recall started
10 May 2021
Terminated
15 December 2022
Reason
Elevated rates of false negative results may occur when using blood culture panels due to issues in the manufacturing process. Pouches contained OPP from FilmArray Blood Culture Identification Panel (BCID) instead of OPP from BCID2 Panel.
Distribution
US nationwide distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-1903-2021

Terminated Class II Medical devices

Recall started
16 April 2021
Terminated
2 April 2024
Reason
Elevated rates of false positive/false negative and control failures while using the Pneumonia Panel, due to issues identified in the manufacturing process.
Distribution
U.S. Nationwide distribution in the states of MN and OK. O.U.S.: None
Initiated
Voluntary: Firm initiated
Recall number
Z-1944-2021

Terminated Class II Medical devices

Recall started
26 January 2021
Terminated
2 May 2022
Reason
The firm has identified an increased risk of false positive Pseudomonas aeruginosa when BCID/BCID2 Panels are used with specific BD BACTEC" blood culture vials.
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Afghanistan, Angola, Anguilla , Argentina, Australia, Austria, Bahrain, Belarus, Belgium, Bolivia, Brazil, Brunei. Daruss., Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Cote d'Ivoire, Croatia, Czech Republic, Dominican
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1157-2021, Z-1158-2021

Terminated Class II Medical devices

Recall started
22 January 2020
Terminated
14 April 2021
Reason
There is an increased risk of false positive Proteus results when using the Film Array Blood Culture Identification Panel (BCID) in vitro diagnostic test of blood cultures used in conjunction with specific media types. False positive Proteus results from this test may lead to patients receiving improper antibiotic treatment until culture results are available (within 24-48 hours).
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Argentina, Austria, Australia, Azerbaijan, Belgium, Bosnia-Herz., Botswana, Brazil, Bulgaria, Burkina Faso, Canada, Chile, Columbia, Costa Rica, Croatia, Czech Republic, Dominican Republic, Dutch Antilles, Ecuador, Egypt, El Sa
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2295-2020, Z-2296-2020

Terminated Class II Medical devices

Recall started
8 August 2019
Terminated
12 April 2022
Reason
Complaints have been received concerning elevated rates of false negative results while using the Gastrointestinal (GI) Panel. False negative results may lead to incorrect treatment being provided which could potentially lead to more serious health events.
Distribution
US: KY, IL, NJ, MS
Initiated
Voluntary: Firm initiated
Recall number
Z-1451-2020

Terminated Class II Medical devices

Recall started
7 March 2019
Terminated
24 August 2022
Reason
Increased risk of false positive Enterobacteriaceae and Escherichia coli results on affected blood culture identification panels when using certain blood culture bottles.
Distribution
MA, NH, VT, CT, NJ, NY, PA, DE, DC, VA, MD, WV, NC, SC, GA, FL, AL, TN, MS, KY, OH, IN, MI, IA, WI, MN, SD, ND, MT, IL, MO, KS, NE, LA, AR, OK, TX, CO, WY, ID, UT, AZ, NM, NV, CA, HI, OR, WA, AK, BM
Initiated
Voluntary: Firm initiated
Recall number
Z-1133-2019

Terminated Class II Medical devices

Recall started
6 March 2019
Terminated
18 February 2022
Reason
Elevated rates of false positive results for Campylobacter and Cryptosporidium have been identified.
Distribution
Worldwide Distribution - US Nationwide in the states of: CO, IL, NJ, PA, OH, FL, KY, NE, NY, CA, WV, UT, TX, MS, OK, WI, NC, DE, IN, MN, AK, ND, GA, AR, MO, KS, HI, IA, LA, VA, SC, MT, NM, SD, AL, WY, AZ, WA, TN, OR, MI, MA, NV, MD, CT, DC, VT, ID, NH, RI, ME. Foreign (OUS): Argentina, Austria, A
Initiated
Voluntary: Firm initiated
Recall number
Z-1242-2019

Terminated Class II Medical devices

Recall started
10 September 2018
Terminated
28 April 2021
Reason
Firm identified an issue in the manufacturing process which might contribute to elevated rates of false positive results for HSV-1 while using the ME Panel. Only specific kits are affected.
Distribution
Worldwide Distribution - US Nationwide in the states of: CA DC, FL, IN, KY, MN, MO, NB, NJ, OH, TX and WI. International: Canada, Columbia and Mexico
Initiated
Voluntary: Firm initiated
Recall number
Z-0446-2019

Terminated Class II Medical devices

Recall started
5 September 2018
Terminated
22 March 2021
Reason
Increased risk of false positive results for Proteus when the product is used with a specific blood culture bottles.
Distribution
Worldwide distribution. US nationwide, Kuwait, Lebanon, Malaysia, Myanmar, Nicaragua, Oman, Panama, Paraguay, Peru, Philippines, Qatar, Romania, Saudi Arabia, Slovenia, Uruguay, United Arab Emirates, Vietnam
Initiated
Voluntary: Firm initiated
Recall number
Z-0296-2019

Terminated Class II Medical devices

Recall started
14 March 2018
Terminated
24 October 2018
Reason
There is an increased risk of false positive Proteus results when the product is used with specific types of BD BACTEC blood culture bottles.
Distribution
Distribution was nationwide. There was military/government distribution. Foreign distribution was made to Canada, Algeria, Argentina, Australia, Austria, Bahrain, Botswana, Brazil, Chile, Colombia, Costa Rica, Czech Republic, Dominican Republic, Ecuador, Egypt, France, French Polynesia, Georgia, G
Initiated
Voluntary: Firm initiated
Recall number
Z-1513-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.